- Home
- CPHC vs STRO Comparison
CPHC vs STRO Comparison
Compare CPHC & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHC
- STRO
- Stock Information
- Founded
- CPHC 1994
- STRO 2003
- Country
- CPHC United States
- STRO United States
- Employees
- CPHC N/A
- STRO N/A
- Industry
- CPHC Services-Misc. Amusement & Recreation
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPHC Consumer Discretionary
- STRO Health Care
- Exchange
- CPHC Nasdaq
- STRO Nasdaq
- Market Cap
- CPHC 92.5M
- STRO 68.1M
- IPO Year
- CPHC 1994
- STRO 2018
- Fundamental
- Price
- CPHC $16.94
- STRO $0.83
- Analyst Decision
- CPHC
- STRO Hold
- Analyst Count
- CPHC 0
- STRO 7
- Target Price
- CPHC N/A
- STRO $1.97
- AVG Volume (30 Days)
- CPHC 2.1K
- STRO 473.2K
- Earning Date
- CPHC 11-06-2025
- STRO 11-12-2025
- Dividend Yield
- CPHC 1.66%
- STRO N/A
- EPS Growth
- CPHC N/A
- STRO N/A
- EPS
- CPHC 0.03
- STRO N/A
- Revenue
- CPHC $60,069,270.00
- STRO $104,473,000.00
- Revenue This Year
- CPHC N/A
- STRO $65.48
- Revenue Next Year
- CPHC N/A
- STRO N/A
- P/E Ratio
- CPHC $558.56
- STRO N/A
- Revenue Growth
- CPHC N/A
- STRO N/A
- 52 Week Low
- CPHC $15.91
- STRO $0.52
- 52 Week High
- CPHC $22.93
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- CPHC 54.97
- STRO 44.30
- Support Level
- CPHC $16.40
- STRO $0.79
- Resistance Level
- CPHC $17.40
- STRO $0.89
- Average True Range (ATR)
- CPHC 0.46
- STRO 0.06
- MACD
- CPHC 0.09
- STRO -0.01
- Stochastic Oscillator
- CPHC 69.54
- STRO 24.50
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.